LAVA THERAPEUTICS NV (LVTX) Stock Balance Sheet
NASDAQ:LVTX - Nasdaq - NL0015000AG6 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 33.91M | 90.40M | 14.40M | |||
| Cash Equivalents | 26.96M | N/A | N/A | N/A | N/A | |||
| Marketable Securities | 51.92M | N/A | 61.67M | 42.50M | 118.80M | |||
| Receivables | 1.02M | N/A | 1.70M | 3.30M | 700.00K | |||
| Other Current Assets | 1.63M | 2.72M | 3.33M | 4.40M | 2.60M | |||
| Total Current Assets | 81.54M | 79.00M | 99.00M | 140.50M | 136.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.71M | 1.44M | 2.46M | 2.10M | 1.90M | |||
| Other Non-Current Assets | 114.00K | 90.00K | 320.00K | 800.00K | 800.00K | |||
| Total Non-Current Assets | 1.82M | 2.00M | 3.00M | 2.90M | 2.70M | |||
| TOTAL ASSETS | 83.36M | 81.00M | 102.00M | 143.40M | 139.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 5.76M | 4.89M | 5.28M | 4.60M | 0.00 | |||
| Current Portion Of LT Debt. | 370.00K | N/A | 440.00K | 400.00K | 300.00K | |||
| Accrued Expenses | 6.63M | 10.00M | 5.17M | 7.80M | 1.60M | |||
| Accounts Payable | 2.81M | 2.72M | 4.45M | 4.00M | 2.60M | |||
| Other Current Liabilities | N/A | N/A | 482.00K | 5.10M | 6.90M | |||
| Total Current Liabilities | 15.20M | 18.00M | 15.00M | 22.00M | 11.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 400.00K | 4.60M | |||
| Other Non-Current Liabilities | 35.16M | 35.00M | 35.00M | 35.00M | 5.00M | |||
| Total Non-Current Liabilities | 35.16M | 35.00M | 35.00M | 35.40M | 9.70M | |||
| TOTAL LIABILITIES | 50.36M | 53.00M | 50.00M | 57.40M | 20.90M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -154.57M | -175.00M | -150.00M | -99.10M | -73.50M | |||
| Additional Paid In Capital | 194.45M | 212.00M | 208.00M | 194.40M | 192.30M | |||
| Common Shares | 3.72M | 3.72M | 3.72M | 3.70M | 3.70M | |||
| Other Shareholders' Equity | -10.60M | -13.00M | -11.00M | -13.00M | -4.00M | |||
| Shares Outstanding | 26.30M | 26.00M | 26.00M | 26.30M | 25.80M | |||
| Tangible Book Value per Share | 1.25 | N/A | 1.95 | 3.27 | 4.59 | |||
| Total Shareholders' Equity | 32.99M | 28.00M | 51.00M | 86.00M | 118.40M | |||
| TOTAL LIABILITIES AND EQUITY | 83.36M | 81.00M | 102.00M | 143.40M | 139.20M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | 0.06 | 0.04 | |||
| Current Ratio | 5.36 | 4.39 | 6.60 | 6.39 | 12.19 | |||
| Return On Assets (ROA) | -33.16% | -31.00% | -41.05% | -22.25% | -32.58% | |||
| Return On Equity (ROE) | -83.78% | -89.69% | -82.10% | -37.10% | -38.30% | |||
All data in USD , ROIC based on taxRate of 0.21